Bearish flow noted in aTyr Pharma (ATYR) Inc with 4,292 puts trading, or 2x expected. Most active are Sep-25 3 puts and Sep-25 1 puts, with total volume in those strikes near 3,100 contracts. The Put/Call Ratio is 2.94, while ATM IV is up over 18 points on the day. Earnings are expected on August 14th.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATYR:
- Optimistic Outlook for aTyr Pharma’s Efzofitimod: High-Risk, High-Reward Potential in Phase 3 Trial
- aTyr Pharma Inc put volume heavy and directionally bearish
- aTyr Pharma management to meet with Cantor Fitzgerald
- High-Risk, High-Reward Opportunity in aTyr Pharma’s Efzofitimod Amid Upcoming Phase 3 Readout
- Optimistic Buy Rating for aTyr Pharma Driven by Promising Phase 3 Progress of Efzofitimod in Pulmonary Sarcoidosis